274 related articles for article (PubMed ID: 6145677)
21. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[TBL] [Abstract][Full Text] [Related]
22. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors.
Lavezzo A; Manzoni L; Aureggi G; Nisato D; Bianchetti A; Carminati P
Int J Tissue React; 1984; 6(2):155-65. PubMed ID: 6145676
[TBL] [Abstract][Full Text] [Related]
24. Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog.
Cavanagh RL; Buyniski JP; Schwartz SE
J Pharmacol Exp Ther; 1987 Dec; 243(3):1179-84. PubMed ID: 2891837
[TBL] [Abstract][Full Text] [Related]
25. An analysis of the effects of galanin on gastric acid secretion and plasma levels of gastrin in the dog.
Soldani G; Mengozzi G; Della Longa A; Intorre L; Martelli F; Brown DR
Eur J Pharmacol; 1988 Sep; 154(3):313-8. PubMed ID: 2466671
[TBL] [Abstract][Full Text] [Related]
26. [Intragastric acidity, serum gastrin and serum levels of the H2 receptor oxmetidine administered by continuous infusion].
Wichmann GC; Körber R; Fölsch UR
Arzneimittelforschung; 1985; 35(8):1307-10. PubMed ID: 2866776
[TBL] [Abstract][Full Text] [Related]
27. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
Yamaji Y; Omata T; Abe T; Yoshida A; Ueki S; Aita H; Morita H; Chaki K; Segawa Y; Kurimoto T
Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924
[TBL] [Abstract][Full Text] [Related]
28. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
[TBL] [Abstract][Full Text] [Related]
29. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
[TBL] [Abstract][Full Text] [Related]
30. Effects of omeprazole and ranitidine on gastric acid secretion, blood gastrin levels and [3H]-thymidine incorporation in the oxyntic mucosa from dogs and rats.
Ryberg B; Mattsson H; Carlsson E
Digestion; 1988; 39(2):91-9. PubMed ID: 3410171
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells.
Stachura J; Konturek SJ; Cieszkowsky M; Dabroś W; Zakrzewska J; Konturek J
Hepatogastroenterology; 1983 Oct; 30(5):205-10. PubMed ID: 6315556
[TBL] [Abstract][Full Text] [Related]
32. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
[TBL] [Abstract][Full Text] [Related]
33. Gastric antisecretory effects of compound BP 2-94: a histamine H3-receptor agonist prodrug.
Soldani G; Bertini S; Rouleau A; Schwartz JC; Coruzzi G
Dig Dis Sci; 1999 Dec; 44(12):2380-5. PubMed ID: 10630485
[TBL] [Abstract][Full Text] [Related]
34. Isolated gastric mucosa: an early approach to the study of the mechanism of action of gastric antisecretory agents.
Colombo M; Fort M; Farré AJ
Methods Find Exp Clin Pharmacol; 1989 Oct; 11(10):621-34. PubMed ID: 2573753
[TBL] [Abstract][Full Text] [Related]
35. [Oxmetidine--a new H2-receptor antagonist].
Gugler R
Dtsch Med Wochenschr; 1983 Nov; 108(47):1809-11. PubMed ID: 6641532
[No Abstract] [Full Text] [Related]
36. Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
Ciociola AA; Webb DD; Heath A; Walsh JH
Aliment Pharmacol Ther; 1996 Dec; 10(6):905-12. PubMed ID: 8971287
[TBL] [Abstract][Full Text] [Related]
37. Apparent irreversible H2-receptor blocking and prolonged gastric antisecretory activities of 3-N-(3-[3-(1-piperidinomethyl)phenoxy]propyl) amino-4-amino-1,2,5-thiadiazole-1-oxide (L-643, 441).
Torchiana ML; Pendleton RG; Cook PG; Hanson CA; Clineschmidt BV
J Pharmacol Exp Ther; 1983 Mar; 224(3):514-9. PubMed ID: 6131118
[TBL] [Abstract][Full Text] [Related]
38. Effects of ranitidine and oxmetidine on gastrointestinal motility in conscious dog.
Fioramonti J; Soldani G; Honde C; Bueno L
Agents Actions; 1984 Oct; 15(3-4):260-3. PubMed ID: 6098172
[TBL] [Abstract][Full Text] [Related]
39. Short-term and long-term effects of ranitidine and oxmetidine on gastrointestinal motility in sheep.
Soldani G; Del Tacca M; Ruckebusch Y
Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):70-4. PubMed ID: 6145395
[TBL] [Abstract][Full Text] [Related]
40. Effects of pirenzepine and atropine on vagal and cholinergic gastric secretion and gastrin release and on heart rate in the dog.
Hirschowitz BI; Fong J; Molina E
J Pharmacol Exp Ther; 1983 May; 225(2):263-8. PubMed ID: 6132990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
